Cargando…
Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938495/ https://www.ncbi.nlm.nih.gov/pubmed/34303653 http://dx.doi.org/10.1016/j.htct.2021.02.010 |
| _version_ | 1784890644646330368 |
|---|---|
| author | Camelo, Ricardo Mesquita de Medeiros, Tenille Capuxú de Albuquerque, Daniela Gonçalves Braz Álvares-Teodoro, Juliana |
| author_facet | Camelo, Ricardo Mesquita de Medeiros, Tenille Capuxú de Albuquerque, Daniela Gonçalves Braz Álvares-Teodoro, Juliana |
| author_sort | Camelo, Ricardo Mesquita |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9938495 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Sociedade Brasileira de Hematologia e Hemoterapia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99384952023-02-19 Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes Camelo, Ricardo Mesquita de Medeiros, Tenille Capuxú de Albuquerque, Daniela Gonçalves Braz Álvares-Teodoro, Juliana Hematol Transfus Cell Ther Case Report Sociedade Brasileira de Hematologia e Hemoterapia 2023 2021-05-07 /pmc/articles/PMC9938495/ /pubmed/34303653 http://dx.doi.org/10.1016/j.htct.2021.02.010 Text en © 2021 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Case Report Camelo, Ricardo Mesquita de Medeiros, Tenille Capuxú de Albuquerque, Daniela Gonçalves Braz Álvares-Teodoro, Juliana Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes |
| title | Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes |
| title_full | Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes |
| title_fullStr | Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes |
| title_full_unstemmed | Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes |
| title_short | Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes |
| title_sort | twelve months of emicizumab prophylaxis in a severe hemophilia a man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938495/ https://www.ncbi.nlm.nih.gov/pubmed/34303653 http://dx.doi.org/10.1016/j.htct.2021.02.010 |
| work_keys_str_mv | AT cameloricardomesquita twelvemonthsofemicizumabprophylaxisinaseverehemophiliaamanwithinhibitorwhofailedimmunetoleranceinductioneffectivenesseconomicandsafetyoutcomes AT demedeirostenillecapuxu twelvemonthsofemicizumabprophylaxisinaseverehemophiliaamanwithinhibitorwhofailedimmunetoleranceinductioneffectivenesseconomicandsafetyoutcomes AT dealbuquerquedanielagoncalvesbraz twelvemonthsofemicizumabprophylaxisinaseverehemophiliaamanwithinhibitorwhofailedimmunetoleranceinductioneffectivenesseconomicandsafetyoutcomes AT alvaresteodorojuliana twelvemonthsofemicizumabprophylaxisinaseverehemophiliaamanwithinhibitorwhofailedimmunetoleranceinductioneffectivenesseconomicandsafetyoutcomes |